Evidence map›Paper›PMID 38243271›Full record

ArticleBMC infectious diseases2024

State transitions across the Strep A disease spectrum: scoping review and evidence gaps.

Prerana Parajulee, Jung-Seok Lee, Kaja Abbas, Jeffrey Cannon, Jean Louis Excler, Jerome H Kim, Vittal Mogasale

Abstract readScoping Review
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Prerana ParajuleeInternational Vaccine Institute, Seoul, Republic of Korea. prerana.parajulee@ivi.int.
Jung-Seok LeeInternational Vaccine Institute, Seoul, Republic of Korea.
Kaja AbbasLondon School of Hygiene and Tropical Medicine, London, UK.
Jeffrey CannonTelethon Kids Institute, University of Western Australia, Perth, Australia.
Jean Louis ExclerInternational Vaccine Institute, Seoul, Republic of Korea.
Jerome H KimInternational Vaccine Institute, Seoul, Republic of Korea.
Vittal MogasaleInternational Vaccine Institute, Seoul, Republic of Korea.

Funding

Wellcome TrustWellcome Trust 215490/Z/19/ZWorld Health Organization 001
6 · The paper itself

Abstract

The spectrum of diseases caused by Streptococcus pyogenes (Strep A) ranges from superficial to serious life-threatening invasive infections. We conducted a scoping review of published articles between 1980 and 2021 to synthesize evidence of state transitions across the Strep A disease spectrum. We identified 175 articles reporting 262 distinct observations of Strep A disease state transitions. Among the included articles, the transition from an invasive or toxin-mediated disease state to another disease state (i.e., to recurrent ARF, RHD or death) was described 115 times (43.9% of all included transition pairs) while the transition to and from locally invasive category was the lowest (n = 7; 0.02%). Transitions from well to any other state was most frequently reported (49%) whereas a relatively higher number of studies (n = 71) reported transition from invasive disease to death. Transitions from any disease state to locally invasive, Strep A pharyngitis to invasive disease, and chronic kidney disease to death were lacking. Transitions related to severe invasive diseases were more frequently reported than superficial ones. Most evidence originated from high-income countries and there is a critical need for new studies in low- and middle-income countries to infer the state transitions across the Strep A disease spectrum in these high-burden settings.

Indexed as

PharyngitisRheumatic FeverStreptococcal InfectionsEvidence GapsHumansStreptococcus pyogenesAcute poststreptococcal glomerulonephritisAcute rheumatic feverGroup A StreptococcusInvasive diseasePharyngitisRheumatic heart diseaseScoping reviewSkin infectionState transitionStrep A disease

Identifiers

PMID38243271
PMCPMC10799450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.